Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03056859 · ClinicalTrials.gov registry record
Compass Device CVC Trial
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 20
- Enrollment target
NCT03056859 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 20 participants.
The verdict
NCT03056859 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is a single-arm observational trial of a device (Compass Vascular Access, Centurion Medical Products, Williamston MI). The device is a compact, sterile, single-use extravascular blood pressure transducer. This pressure measurement aids in confirmation of appropriate venous access. The investigators plan to enroll 40 consenting patients with BMI ≥35 who require central venous catheterization for clinical reasons independent of the existence of this study. The primary outcome is operator satisfaction.
Interventions
- DEVICE Extravascular blood pressure transducer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-02-17 |
| Est. Completion | 2020-02-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03056859
The ClinicalTrials.gov registry entry for NCT03056859 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Extravascular blood pressure transducer is the first listed.
NCT03056859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03056859 about?
NCT03056859 is a clinical study titled "Compass Device CVC Trial". This is a single-arm observational trial of a device (Compass Vascular Access, Centurion Medical Products, Williamston MI). The device is a compact, sterile, single-use extravascular blood pressure transducer. This pressure measurement aids in confirmation of appropriate venous access. The investiga...
What is the current status of trial NCT03056859?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2017-02-17. Estimated completion is 2020-02-10.
What interventions are being tested in trial NCT03056859?
The interventions under investigation include: Extravascular blood pressure transducer (DEVICE).
Who is sponsoring clinical trial NCT03056859?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.